Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 5/20 | 0.31 |
| ▸ | CA1 | P00915 | 5/20 | 0.31 |
| ▸ | CA2 | P00918 | 5/20 | 0.31 |
| ▸ | CA9 | Q16790 | 5/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28886 | 0.94 | APP (0.35) | MAPTMEN1ALDH1A1KMT2ACYP3A4 | |
| Hydrochloric Acid SCHEMBL9124177 | 0.91 | CYP3A4 (0.33) | MAPTMEN1ALDH1A1KMT2ACYP3A4 | |
| SCHEMBL98479 | 0.81 | ENPP2 (0.48) | MAPTMEN1ALDH1A1KMT2AFFAR1 | |
| SCHEMBL1666197 | 0.81 | CA12 (0.50) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL104811 | 0.80 | APP (0.32) | APP | |
| SCHEMBL7057192 | 0.79 | APP (0.57) | MAPTAPPCA12CA1CA2 | |
| SCHEMBL813 | 0.78 | — | — | |
| SCHEMBL7050853 | 0.78 | ALDH1A1 (0.41) | ALDH1A1CYP3A4FFAR1 | |
| SCHEMBL1070722 | 0.76 | CES2 (0.46) | — | |
| SCHEMBL11594853 | 0.76 | ALDH1A1 (0.39) | MEN1ALDH1A1KMT2ACYP3A4CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026150-A1 | POLYETHER KETONE KETONE AND A PROCESS FOR PREPARATION THEREOF | GHARDA CHEMICALS LIMITED (IN) | 2023-01-26 | — | — | US | disclosed |
| WO-2021105784-A1 | POLYETHER KETONE KETONE AND A PROCESS FOR PREPARATION THEREOF | GHARDA CHEMICALS LIMITED (IN) | 2021-06-03 | — | — | WO | disclosed |
| EP-2451858-B1 | METHOD FOR PREPARING POLY (ETHER KETONE KETONES) | KETONEX LTD (GB) | 2020-10-28 | — | — | EP | disclosed |
| EP-3215564-B1 | PROCESSES FOR INCREASING DENSITY OF POLYMER FLAKES AND POWDERS | ARKEMA INC (US) | 2020-09-30 | — | — | EP | disclosed |
| US-10450408-B2 | Method for making polyarylaliphaticetherketone polymers and copolymers thereof | KETONEX LIMITED (GB) | 2019-10-22 | — | — | US | disclosed |
| US-10377846-B2 | Processes for increasing density of polymer flakes and powders | ARKEMA INC. (US) | 2019-08-13 | — | — | US | disclosed |
| US-20170306075-A1 | PROCESSES FOR INCREASING DENSITY OF POLYMER FLAKES AND POWDERS | ARKEMA INC. | 2017-10-26 | — | — | US | disclosed |
| EP-3215564-A2 | PROCESSES FOR INCREASING DENSITY OF POLYMER FLAKES AND POWDERS | Arkema, Inc. (US) | 2017-09-13 | — | — | EP | disclosed |
| US-20170253696-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | OXFORD PERFORMANCE MATERIALS, INC | 2017-09-07 | — | — | US | disclosed |
| EP-3191442-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | Ketonex Limited (GB) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016038370-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | KETONEX LIMITED (GB) | 2016-03-17 | — | — | WO | disclosed |
| US-9023468-B2 | Method for preparing poly (ether ketone ketones) | KETONEX LIMITED (GB) | 2015-05-05 | — | — | US | disclosed |
| US-20120263953-A1 | METHOD FOR PREPARING POLY (ETHER KETONE KETONES) | KETONEX LIMITED (GB) | 2012-10-18 | — | — | US | disclosed |
| EP-2451858-A2 | METHOD FOR PREPARING POLY (ETHER KETONE KETONES) | Ketonex Limited (GB) | 2012-05-16 | — | — | EP | disclosed |
| WO-2011004164-A2 | METHOD FOR PREPARING POLY (ETHER KETONE KETONES) | KETONEX LIMITED (GB) | 2011-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450408-B2 | Method for making polyarylaliphaticetherketone polymers and copolymers thereof | DAO, DCXR, LOX | MAPT 4080/4885MEN1 4480/4885ALDH1A1 815/4885 |
| US-20170253696-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | COASY, FRK, PBK | MAPT 3631/4885MEN1 4316/4885ALDH1A1 1358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.